<DOC>
	<DOCNO>NCT00234728</DOCNO>
	<brief_summary>The purpose study determine new dress design used topical medication enhance effect topical medication .</brief_summary>
	<brief_title>Study New Dressing Use With Topical Medications</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Subject sign informed consent form HIPAA authorization form Male female subject least 18 year age A diagnosis stable plaquetype psoriasis vulgaris least one `` mirror image '' pair symmetric lesion either trunk , arm , leg would serve target lesion . Paired target lesion must similar anatomic location ( e.g. , right leave elbows right left knee ) roughly equal ( one point difference ) modify PASI score . Both paired target lesion must PASI score equal great 1.5 Any additional diagnosis must , investigator 's opinion , preclude subject safely participate study interfere evaluation subject 's psoriasis Psoriasis must clinically stable least 30 day enrollment Subject able completely discontinue use medication therapy relief psoriasis target area treat Subject able completely discontinue use systemic medication therapy ( e.g . oral injectable psoriasis medication , PUVA phototherapy , herbal remedy , acupuncture ) relief psoriasis Female subject must postmenopausal ( define one year without menses ) , physically incapable become pregnant , use acceptable birth control method . Acceptable method birth control include hormonal contraceptive doublebarrier method ( condom , diaphragm spermicidal agent IUD ) . If practice acceptable method birth control , subject must confirmation negative urine pregnancy test Screening Subject must reliable mentally competent complete study measurement Subject able understand agree comply study requirement , attend study visit , comply restriction study . Subject skin disorder psoriasis target area evaluate Known hypersensitivity component test medication Pigmentation , extensive scarring , pigment lesion affected area would interfere evaluation efficacy parameter Clinically infect psoriasis baseline Subject pregnant nursing Guttate , pustular , erythrodermic , nonplaque form psoriasis Spontaneously worsen improve psoriasis within 30 day enrollment Any evidence atrophy area select treatment topical corticosteroid History treat potential target lesion differently one another Topical intralesional therapy ( emollient ) UVB phototherapy potential target lesion within two week start study treatment Systemic therapy , PUVA phototherapy , systemic investigational therapy psoriasis within 30 day prior study entry Treatment topical investigational therapy target lesion within 30 day prior study entry Subject consider unreliable medication compliance adherence schedule appointment determine investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>hydrogel</keyword>
	<keyword>occlusive dressing</keyword>
	<keyword>occlusion</keyword>
	<keyword>hydrocortisone</keyword>
	<keyword>tacrolimus</keyword>
	<keyword>Protopic</keyword>
	<keyword>triamcinolone</keyword>
	<keyword>calcipotriene</keyword>
	<keyword>Dovonex</keyword>
	<keyword>halobetasol</keyword>
	<keyword>Ultravate</keyword>
</DOC>